2025-06-10-Jefferies-燃料电池公司（FCEL）_第二季度模型更新；整顿局面；进一步重组_9页_160kb

FuelCell Energy (FCEL) Equity Research Summary

Date: June 10, 2025
RATING: HOLD
PRICE TARGET: $7.80 (previously $7.47)

Key Highlights

1. Recent Performance and Restructuring

• 2Q Results: Revenue of ~$37.4mn (beat consensus $32.4mn), GM at -25% (missed consensus -9%).
• EBITDA: -$19mn (missed consensus -$16mn), generation EBITDA margin of 28% (vs JEFe of 24%).
• Restructuring Plan: Management plans to slash OpEx by 30% YoY (from FY24), including workforce reduction (from ~16.5M shares to ~12.8M), R&D cutback, and reduced SG&A.
• Focus: Align production at Torrington facility (31MW capacity) with contracted demand.

2. Path to Positive EBITDA

• Torrington facility at 100% utilization could yield positive EBITDA.
• Revenue outlook: FY26E: $142mn, PT $7.80 (1.2x P/sales vs prior 1.5x).

3. Strategic Initiatives

• DPP Partnership: Supplying 360MW of power to data centers in VA, WV, KY; awaiting offtake agreements.
• Project Financing: Actively seeking project financing (e.g., EXIM Bank debt deal) to fund Korea repowering project.
• Technology: Prioritizing SO electrolyzers and carbon capture solutions to drive orders.

4. Valuation & Risks

• Valuation: PT $7.80 based on 1.2x sales for FY26. Current market cap: $101M, trading at 0.9x prior-year sales.
• Upside Catalysts: Solid oxide orders, data center partnerships.
• Downside Risks: Execution risks on generation projects, delayed commercialization, weak sales growth.

5. Audience & Analyst Certification

• Jefferies analysts: Dushyant Ailani, Julien Dumoulin-Smith, Paul Zimbardo, Whitney Mutalemwa.
• Disclosure: Analyst compensation tied to firm performance, potential conflicts with FCEL client relationships.

Financial Data (FY2Q25)

• Revenue: $37.4M (-19% YoQ)
• EBITDA: -$19M (exceeding loss of -$16M)
• Cash & Eq.: $240M; debt refinanced in 2Q.

Company Description

Develops fuel cell power plants for power generation, with research contracts for marine applications.

Analyst Ratings History

• Previous PTs: $9.50 (Sep 2024), $15.00 (Sep 2024).
• Distribution chart shows analyst confidence amid volatile coverage.

---

Note: This summary captures key points from the equity research, including financials, strategic moves, valuation, and analyst certifications.